Unknown

Dataset Information

0

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?


ABSTRACT: Brazil is a low-and-middle income country (LMIC) that, despite having a large population and continental dimensions, has been able to successfully fight HIV/AIDS through a number of governmental and societal measures. These included an early response to the epidemic, the development of a universal and free public health system, incisive discussions with pharmaceutical companies to reduce antiretroviral (ARV) drug prices, investments towards the development of generic drugs and compulsory licensing of ARVs. Through such measures, Brazil is among the leading LMIC towards achieving the 90-90-90 UNAIDS goals in the years to come. In this review, we analyze Brazil's progress throughout the HIV/AIDS epidemic to achieve state-of-the-art ARV treatment and to reduce AIDS mortality in the country. The top-quality HIV/AIDS research in Brazil towards HIV prophylactic and functional cure, the next step towards the economic sustainability of the battle against HIV, is also discussed.

SUBMITTER: Benzaken AS 

PROVIDER: S-EPMC6694665 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?

Benzaken Adele S AS   Pereira Gerson F M GFM   Costa Lendel L   Tanuri Amilcar A   Santos André F AF   Soares Marcelo A MA  

AIDS research and therapy 20190814 1


Brazil is a low-and-middle income country (LMIC) that, despite having a large population and continental dimensions, has been able to successfully fight HIV/AIDS through a number of governmental and societal measures. These included an early response to the epidemic, the development of a universal and free public health system, incisive discussions with pharmaceutical companies to reduce antiretroviral (ARV) drug prices, investments towards the development of generic drugs and compulsory licensi  ...[more]

Similar Datasets

| S-EPMC6396460 | biostudies-literature
| S-EPMC7238401 | biostudies-literature
| S-EPMC6202867 | biostudies-other
| S-EPMC3799464 | biostudies-literature
| S-EPMC3592862 | biostudies-literature
| S-EPMC6543648 | biostudies-literature
| S-EPMC4925286 | biostudies-literature
| S-EPMC5612457 | biostudies-literature
| S-EPMC4232561 | biostudies-other
| S-EPMC2936574 | biostudies-literature